Evidence map›Paper›PMID 34489265›Full record

ArticleBMJ open2021

Association between serum phosphate and mortality in critically ill patients: a large retrospective cohort study.

Yang Chen, Mengdi Luo, Huange Xu, Weiwei Zhao, Qing He

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yang ChenEmergency, Affiliated Hospital of Southwest Jiaotong University / The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Mengdi LuoEmergency, Affiliated Hospital of Southwest Jiaotong University / The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Huange XuClinical College, Southwest Jiaotong University, Chengdu, Sichuan, China.
Weiwei ZhaoClinical College, Southwest Jiaotong University, Chengdu, Sichuan, China.
Qing HeEmergency, Affiliated Hospital of Southwest Jiaotong University / The Third People's Hospital of Chengdu, Chengdu, Sichuan, China kk555888@126.com.ORCID 0000-0002-4803-1813
Third People's Hospital of Chengdu · CNSouthwest Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis research aims to explore the impact of serum phosphate on the mortality of critically ill patients.

designA retrospective large cohort study.

settingOur data were extracted from a publicly accessible database named 'Multiparameter Intelligent Monitoring in Intensive Care Database III'.

participants27 131 patients were included by clear definitions of selection and exclusion criteria.

interventionsWe used initial phosphate at admission as a design variable. Patients were divided into six groups with different serum phosphate levels and five groups at different intensive care unit (ICU) departments. PRIMARY AND SECONDARY OUTCOMES: 28-day and 90-day mortality were primary outcomes. All-cause mortality and length of stay ICU were secondary outcomes.

resultsPatients with very-high-normal serum phosphate, hypophosphataemia and hyperphosphataemia had worse outcomes. And the relationship between serum phosphate and the probability of 28-day or 90-day mortality had a linear relationship. After adjustment for potential confounders, hypophosphataemia and hyperphosphataemia were not significantly associated with 28-day or 90-day mortality. Nevertheless, at the medical ICU, hyperphosphataemia was associated with increased 28-day or 90-day mortality (HR=0.64, 95% CI 0.48 to 0.84, p=0.0017; HR=0.72, 95% CI 0.57 to 0.91, p=0.0067, respectively), using group 2 (≥2.5 mg/dL and <3.0 mg/dL) as the reference group.

conclusionsPatients with very-high-normal serum phosphate also had worse outcomes, it might be necessary to re-evaluate the definitions of the normal reference range for serum phosphate. Hypophosphataemia and hyperphosphataemia are not the independent risk factors of 28-day or 90-day ICU mortality, which leads us to consider whether phosphate monitoring is not a necessary measure in critically ill patients. But hyperphosphataemia was associated with increased 28-day or 90-day mortality at the medical ICU, which emphasises the potential importance of early diagnosis and treatment of hyperphosphataemia for the patients who were admitted to the medical ICU.

Indexed as

Critical IllnessIntensive Care UnitsCohort StudiesHospital MortalityHumansPhosphatesRetrospective StudiesPhosphatesadult intensive & critical carehuman resource managementintensive & critical care

Identifiers

PMID34489265
PMCPMC8422318
OpenAlexW3197752772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.